1,4-dihydropyridine has been researched along with Brain Vascular Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altura, BM; Altura, BT | 1 |
Bianchi, A; Capizzi, RL; Capuzzi, DM; D'Armiento, FP; de Nigris, F; Donzelli, R; Godfraind, T; Gonnella, JS; Mancini, M; Napoli, C; Palinski, W; Palumbo, G; Salomone, S | 1 |
Rudin, M; Sauter, A | 1 |
1 review(s) available for 1,4-dihydropyridine and Brain Vascular Disorders
Article | Year |
---|---|
Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Topics: Anesthesia; Animals; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Cell Membrane Permeability; Cerebrovascular Circulation; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus; Dihydropyridines; Female; Humans; Hypertension; Ketamine; Magnesium; Magnesium Deficiency; Microcirculation; Muscle, Smooth, Vascular; Muscles; Nifedipine; Nisoldipine; Nitrendipine; Nutritional Requirements; Pentobarbital; Pre-Eclampsia; Pregnancy; Pyridines; Rats; Vasoconstrictor Agents; Vasodilator Agents; Venules | 1984 |
2 other study(ies) available for 1,4-dihydropyridine and Brain Vascular Disorders
Article | Year |
---|---|
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
Topics: Animals; Antioxidants; Apolipoproteins B; Arteries; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Epitopes; Genetic Predisposition to Disease; Immunohistochemistry; Lipoproteins, LDL; Male; Oxidation-Reduction; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Vitamin E | 1999 |
Prevention of stroke and brain damage with calcium antagonists in animals.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Damage, Chronic; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Isradipine; Male; Prognosis; Pyridines; Rats; Rats, Inbred SHR | 1991 |